Possible rationale for procaine (Gerovital H3) therapy in geriatrics: inhibition of monoamine oxidase.
D000368:Aged; D000375:Aging / Q000187:drug effects*; D000588:Amines / Q000378:metabolism; D000818:Animals; D001681:Biological Assay; D001921:Brain / Q000378:metabolism; D002395:Catecholamines / Q000502:physiology; D003863:Depression / Q000188:drug therapy; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007490:Iproniazid / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D011343:Procaine / Q000627:therapeutic use*; D011427:Propiophenones / Q000378:metabolism; D051381:Rats; D012701:Serotonin / Q000378:metabolism
D000588:Amines; D002395:Catecholamines; D008996:Monoamine Oxidase Inhibitors; D011427:Propiophenones; D012701:Serotonin; D011343:Procaine; D007490:Iproniazid